Package: BayesDesign 0.1.1

BayesDesign: Bayesian Single-Arm Design with Survival Endpoints

The proposed event-driven approach for Bayesian two-stage single-arm phase II trial design is a novel clinical trial design and can be regarded as an extension of the Simon’s two-stage design with the time-to-event endpoint. This design is motivated by cancer clinical trials with immunotherapy and molecularly targeted therapy, in which time-to-event endpoint is often a desired endpoint.

Authors:Chia-Wei Hsu [aut, cre], Haitao Pan [aut], Jianrong Wu [aut]